Status:
COMPLETED
Enhancing the Secondary Prevention of Coronary Artery Disease
Lead Sponsor:
University of Alberta
Collaborating Sponsors:
Heart and Stroke Foundation of Canada
Alberta Heritage Foundation for Medical Research
Conditions:
Coronary Disease
Ischemic Heart Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
People with coronary artery disease can reduce their chance of having a heart attack by making healthy lifestyle choices (diet, exercise, quitting smoking,etc.). There are also many medications that h...
Detailed Description
BACKGROUND: Despite the abundant evidence base for secondary prevention, practice audits consistently demonstrate substantial "care gaps" between this evidence and clinical reality such that many pati...
Eligibility Criteria
Inclusion
- Alberta residents who undergo a cardiac catheterization and are diagnosed with coronary artery disease (\> or equal to 50% stenosis in at least one vessel).
Exclusion
- no fasting lipid panel within the previous 6 weeks
- on a statin at maximal dose
- on a statin/lipid lowering drug and LDL-C is 2.5 mmol/L or less (prior to Sept 2006) and LDL-C is 2.0 mmol/L or less (after Sept 2006)
- not on a statin and LDL-C is 1.8 mmol/L or less
- acute myocardial infarction or cardiogenic shock
- require emergency bypass surgery following catheterization
- contraindication to statins (e.g. cirrhosis, inflammatory muscle disease)
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2015
Estimated Enrollment :
480 Patients enrolled
Trial Details
Trial ID
NCT00175240
Start Date
March 1 2005
End Date
July 1 2015
Last Update
July 28 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alberta Hospital; Royal Alexandra Hospital, Foothills Medical Centre (Calgary)
Edmonton, Alberta, Canada, T6G 2B7